The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis

Chronic low-grade inflammation has been suspected to promote atherosclerosis. Here, Geng et al. show that sustained low-grade inflammation promotes atherosclerosis in mice via monocyte programing that involves a coupled disruption of IRAK-M regulation and induction of miR-24.

Guardado en:
Detalles Bibliográficos
Autores principales: Shuo Geng, Keqiang Chen, Ruoxi Yuan, Liang Peng, Urmila Maitra, Na Diao, Chun Chen, Yao Zhang, Yuan Hu, Chen-Feng Qi, Susan Pierce, Wenhua Ling, Huabao Xiong, Liwu Li
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2016
Materias:
Q
Acceso en línea:https://doaj.org/article/ffa51fe5e51e4e3e90bbf675912cbc4a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ffa51fe5e51e4e3e90bbf675912cbc4a
record_format dspace
spelling oai:doaj.org-article:ffa51fe5e51e4e3e90bbf675912cbc4a2021-12-02T15:35:45ZThe persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis10.1038/ncomms134362041-1723https://doaj.org/article/ffa51fe5e51e4e3e90bbf675912cbc4a2016-11-01T00:00:00Zhttps://doi.org/10.1038/ncomms13436https://doaj.org/toc/2041-1723Chronic low-grade inflammation has been suspected to promote atherosclerosis. Here, Geng et al. show that sustained low-grade inflammation promotes atherosclerosis in mice via monocyte programing that involves a coupled disruption of IRAK-M regulation and induction of miR-24.Shuo GengKeqiang ChenRuoxi YuanLiang PengUrmila MaitraNa DiaoChun ChenYao ZhangYuan HuChen-Feng QiSusan PierceWenhua LingHuabao XiongLiwu LiNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-15 (2016)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Shuo Geng
Keqiang Chen
Ruoxi Yuan
Liang Peng
Urmila Maitra
Na Diao
Chun Chen
Yao Zhang
Yuan Hu
Chen-Feng Qi
Susan Pierce
Wenhua Ling
Huabao Xiong
Liwu Li
The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis
description Chronic low-grade inflammation has been suspected to promote atherosclerosis. Here, Geng et al. show that sustained low-grade inflammation promotes atherosclerosis in mice via monocyte programing that involves a coupled disruption of IRAK-M regulation and induction of miR-24.
format article
author Shuo Geng
Keqiang Chen
Ruoxi Yuan
Liang Peng
Urmila Maitra
Na Diao
Chun Chen
Yao Zhang
Yuan Hu
Chen-Feng Qi
Susan Pierce
Wenhua Ling
Huabao Xiong
Liwu Li
author_facet Shuo Geng
Keqiang Chen
Ruoxi Yuan
Liang Peng
Urmila Maitra
Na Diao
Chun Chen
Yao Zhang
Yuan Hu
Chen-Feng Qi
Susan Pierce
Wenhua Ling
Huabao Xiong
Liwu Li
author_sort Shuo Geng
title The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis
title_short The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis
title_full The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis
title_fullStr The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis
title_full_unstemmed The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis
title_sort persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis
publisher Nature Portfolio
publishDate 2016
url https://doaj.org/article/ffa51fe5e51e4e3e90bbf675912cbc4a
work_keys_str_mv AT shuogeng thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT keqiangchen thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT ruoxiyuan thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT liangpeng thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT urmilamaitra thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT nadiao thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT chunchen thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT yaozhang thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT yuanhu thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT chenfengqi thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT susanpierce thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT wenhualing thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT huabaoxiong thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT liwuli thepersistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT shuogeng persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT keqiangchen persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT ruoxiyuan persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT liangpeng persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT urmilamaitra persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT nadiao persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT chunchen persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT yaozhang persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT yuanhu persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT chenfengqi persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT susanpierce persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT wenhualing persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT huabaoxiong persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
AT liwuli persistenceoflowgradeinflammatorymonocytescontributestoaggravatedatherosclerosis
_version_ 1718386512718987264